NDUFA6-DT: A Drug Target / Disease Biomarker (G100132273)

Target Name: NDUFA6-DT

NCBI ID: G100132273

NDUFA6-DT

Other Name(s): NDUFA6-AS1 | NDUFA6 divergent transcript

NDUFA6-DT: A Drug Target / Disease Biomarker

NDUFA6-DT is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and muscle. Its full name is neuroendoplasmic reticulum-associated protein 6 (NDUFA6), and it has been identified as a potential drug target or biomarker for various diseases.

NDUFA6 is a member of the endoplasmic reticulum (ER) transmembrane protein family, which includes a variety of proteins that play important roles in the ER-to-cell membrane transport of proteins and other molecules. These proteins help to maintain the ER-to-cell membrane potential, which is critical for the proper functioning of the cell.

NDUFA6 is involved in a number of different cellular processes that are critical for the development and maintenance of the brain. For example, it is involved in the transport of proteins involved in synaptic transmission, such as the neurotransmitter acetylcholine. It is also involved in the transport of oxygen and nutrients to the brain, which is essential for maintaining its health and function.

NDUFA6 has also been shown to be involved in the development and progression of a number of neurological and psychiatric diseases, including Alzheimer's disease, Parkinson's disease, and depression. Studies have shown that NDUFA6 levels are often decreased in individuals with these conditions, and that inhibiting its activity may be a potential therapeutic approach.

In addition to its potential therapeutic applications, NDUFA6 is also a potential biomarker for these diseases. The levels of NDUFA6 have been shown to be altered in a number of ways in individuals with Alzheimer's disease, Parkinson's disease, and depression, and these changes have been associated with the progression of these conditions. Therefore, measuring the levels of NDUFA6 in individuals may be a potential diagnostic tool for these diseases.

Overall, NDUFA6 is a protein that is involved in a number of important cellular processes that are critical for the development and maintenance of the brain. Its potential as a drug target or biomarker for various neurological and psychiatric diseases makes it an important area of research. Further studies are needed to fully understand its role in these processes and to develop effective therapies.

Protein Name: NDUFA6 Divergent Transcript

The "NDUFA6-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFA6-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets